Last updated on December 2019

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The objective of this study is to evaluate the efficacy and safety of Upadacitinib compared to placebo in inducing clinical remission (per Adapted Mayo score) in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03653026

Find a site near you

Start Over

MD Search /ID# 208084

Boksburg North, South Africa
2.98miles
  Connect »